| Tag | Content |
|---|
EnhancerAtlas ID | HS091-09483 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr12:16511650-16513230 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr12:16513005-16513024 | CAGCGCCCCCTGGTGATGA | - | 6.61 | | MEF2A | MA0052.3 | chr12:16512022-16512034 | GCTAAAAATAGA | + | 6.92 | | MEF2B | MA0660.1 | chr12:16512022-16512034 | GCTAAAAATAGA | + | 6.44 | | MEF2C | MA0497.1 | chr12:16512020-16512035 | TGGCTAAAAATAGAC | + | 6.59 | | SPI1 | MA0080.4 | chr12:16512628-16512642 | CACTTCCCCTTTTA | - | 6.37 | | SPIB | MA0081.2 | chr12:16512628-16512640 | CACTTCCCCTTT | - | 6.07 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_00401 | chr12:16499161-16516054 | Adipose_Nuclei |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I016360 | chr12 | 16512941 | 16513050 |
|
Enhancer Sequence | CTTGGCCTCC CAAAGTGCTG GGATTACAGG CGTGAGCCAC CGGACCTGGC CAAAATTCAT 60
TCCTTTTTTT TTTTTTTTTT TTTTTTTTTT TTACAGCTGT GTAGTATTCC ATGGTGTATA 120
CGTACCACAT TGTCTTTATC CAATTCATAT TGATGGACAC CTAGGTTGCA TTAGCCCTTT 180
TTTGATTCTC TGTGAAAGTC TGAAGCCCCT CCCAAGATTT CTGCAGATTC CCTTATGGCA 240
TATCATCTCC AGGTTAACTC TGGATCTGGG TTCCTGCCTC TATGCATGTT TCCATATTCT 300
GCAATTGGTT ATGCTGGATG TTAATCCAGC CCTTTCATCA GTTCCCTTCA AAAATGAACT 360
AAAAAAAATG TGGCTAAAAA TAGACTTGAG TAAGTGGAAG TGCAGAGGCG TTTACACTGT 420
GGCAGCACAA ACATTTTAAG TTGTATGTTA TTTCTCTGTC AGACAATGGC CTTCAGCGTC 480
CTCTCTTTGC AGAATATGCC CCGTACCTGT ACCTCCTTCA CGCAAGCAAT GCCCAGTGTT 540
ACACCATTTT TGAGGCTCTC CTCTAGCCCC ACAGACTCTT CAACCTTTTC AGCACTAAAA 600
TTAAAAGTAC CTTCTTGCTC ATGCAAAACA ATTCTACCCC CAAGCTATTC ATCAAGCAAG 660
AATGTTTCTC TTCTAAGAAG AAGTCTGTGC AGATACTTAG CACAAAATTT CACCTTCTAT 720
CTCACTTAGT TATATACTTC TTAATTCAGC AGCCCTGCTG AGTAAATCAG TGAGTCTTGA 780
GAATGGGTTG TGTCAAGAAT ATGGATATAA AATAGTTTCA GGACAAAGAA TCACTGTGGA 840
AATTTCAAAC AGCAGAACAA TATCAAAGGA AAAATTATGT GTTAGACGAA AAAAAATAAA 900
AAAAAGTGAG TGAAGCTTAA GTTTTCAAAA CCACTGAAGA GACATGAAAA CTTTTAAAGC 960
CTTGTCTGGT CCTTTATGCA CTTCCCCTTT TAGAGCAGGC AGCCGCCTGC ATGATGCTAG 1020
TCATGGCCCT GTATTTATAA AATTGCCCAG AACTGGAAAG TGATCAGAAG CAATTAGACC 1080
CTCAGTAGTA TTAGTAAGAC TGAAATGAAA ATCCAAGTAA GTCTCCTGTG TGAAAGCGTA 1140
ACAAAAGATA TTTTATTTGG GGATTTTAGA TTCCTCCCTA CTATTCTTTC CGACCTTCCA 1200
CCCTTACTCC CTGCCCGTGG GATTGTACTT TTAGAGGAAA ACGACGTTAT CTAAATTGAT 1260
CCGCTAGTCA GGTTGCAAAT GAATGTTAGA AAGAACAATT GACCCCAGTT CTGTAAAGGT 1320
TCCGAGTCCT GGAGGAGGTG CAGCGACTGT GTGCACAGCG CCCCCTGGTG ATGAGACACT 1380
GGCTTTTCCG CATACTGAGA GAAGAGCGTC TCCAACAGAG CGGAGTTTCC AGTTGTATAA 1440
TGCTTTTTGA GACAGTACCT GTTTCATCGA AAAAGTGCCT AATAACACAC TTTTGGAGAC 1500
ACTTTTCAGA GAGAGCGTTT CCAGCATCTT CCCTTTCCAT TTTTAAGTTA GACTTTTTTT 1560
TTTCACCTCT CTCGTTACTT 1580
|
